Valuation (2%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -68.29 | -16.67 |
PEG Ratio (TTM) | -0.97 | -5.49 |
P/S Ratio (TTM) | N/A | 37.47 |
P/B Ratio (TTM) | 20.51 | 5.86 |
P/FCF Ratio (TTM) | -52.39 | -148.99 |
Price to 5YR AVG Earnings Ratio | N/A | -33.81 |
Price to 5YR AVG FCF Ratio | N/A | -1.26 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -10.14% | 284.65% |
ROE (TTM) | -22.12% | -4,181.05% |
Net Profit Margin (TTM) | N/A | -1,000.23% |
ROIC 5YR AVG | N/A | -16.06% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -41.80% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -27.23% | N/A | N/A |
Cash Flow | 7.94% | N/A | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.13 | 4.92 |
Quick Ratio (TTM) | 0.13 | 4.89 |
D/E Ratio (TTM) | 0.54 | 1.28 |
Interest Coverage (TTM) | -1.18 | -11.13 |
Piotroski F-Score | 3 | 3 |
Altman Z-Score | 5.84 | 20.79 |
LTL to 5YR AVG FCF | N/A | -0.53 |
Shares Outstanding Growth 5YR AVG | N/A | 887.85% |